CN85101662A - The technology of preparation quinoline carboxylic acid derivative - Google Patents
The technology of preparation quinoline carboxylic acid derivative Download PDFInfo
- Publication number
- CN85101662A CN85101662A CN85101662.6A CN85101662A CN85101662A CN 85101662 A CN85101662 A CN 85101662A CN 85101662 A CN85101662 A CN 85101662A CN 85101662 A CN85101662 A CN 85101662A
- Authority
- CN
- China
- Prior art keywords
- compound
- carboxylic acid
- quinoline carboxylic
- fluoro
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Abstract
The invention relates to preparation has the technology of the antiseptic-germicide of important value.Especially about preparing the technology of quinoline carboxylic acid derivative.
Description
The invention relates to preparation 6,8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-4-oxygen-7-(1-piperazine or 4-methyl isophthalic acid-piperazine)-3-quinoline carboxylic acid's technology, this compounds can be used as antiseptic-germicide, its chemical structure such as molecule formula IV
Here R
1Be: hydrogen atom or methyl
Especially the technology of highly purified this class antiseptic-germicide of molecule formula IV of industrial production.Intermediate 6,8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-4-oxygen-7-(1-piperazine or 4-methyl isophthalic acid-piperazine)-3-quinoline carboxylic acid alkyl ester (III) is by corresponding 6,8-two fluoro-7-halo-1-(2-fluoro ethyls)-1,4-dihydro-4-oxygen-3-quinoline carboxylic acid alkyl ester (I) and bridged piperazine derivatives (II) prepared in reaction.
Here R is: the low molecular weight alkyl of 1 to 3 carbon atom, X is: halogen atom.
The R here
1Identical with the molecule formula IV.
Antiseptic-germicide (IV) is obtained by the intermediate compound hydrolysis of molecule formula III
The R here
1With R and molecule formula I, the R of (II)
1, R is identical.
Because our research, during industrial production antiseptic-germicide of the present invention, reached the product purity height, yield is good, handles the level of being easy to.
The concrete practice is, with the mixture heating up of 1 molar molecule formula I compound and 1 to 4 molar bridged piperazine derivatives (II) between the room temperature to 150 ℃, preferably between 40 to 120 ℃, can obtain the compound of molecule formula III, here can have, also can not have solvent or as the alkali of hydrogeneous acid acceptor.Operable alkali has in this reaction: pyridine, picoline (C
6H
7N), triethylamine etc., these organic basess also can be used as reaction solvent.In this reaction, can have: benzene, toluene, methyl-sulphoxide, dimethyl formamide, acetonitrile, spy-butanols etc. as the material of reaction solvent.
6,8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-7-(4-methyl isophthalic acid-piperazine)-4-oxygen-3-quinoline carboxylic acid alkyl ester (III: R
1=CH
3) can be by 6,8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-4-oxygen-7-(1-piperazine)-3-quinoline carboxylic acid alkyl ester (III: R
1=H) and formaldehyde, and the reaction of reductive agent formic acid obtains.
When using acid to be hydrolyzed reaction, preferably use mineral acid example hydrochloric acid, sulfuric acid or organic acid such as acetic acid to mix and heat and finish with intermediate (III).When using alkali to be hydrolyzed reaction, be with intermediate (III) be placed on alkali metal hydroxide (as, sodium hydroxide, potassium hydroxide) dilute solution in and be heated to that 40 to 100 ℃ (preferably 60-95 ℃) finish.
The description and interpretation that following example is done, to the present invention without any restriction.
Example 1
6.7.8-three fluoro-1-(2-fluoro ethyls)-1,4-dihydro-4-oxygen-3-quinoline carboxylic acid ethyl ester
5.36 6.7.8-three fluoro-1 of kilogram, the mixture of the sodium iodide (being dissolved in 20.5 liters of dimethyl formamides) of 4-dihydro-4-oxygen-3-quinoline carboxylic ester and 2.94 kilograms, under 100 ℃ and condition of stirring, the Anhydrous potassium carbonate that adds 2.97 kilograms, after adding mixture was stirred 15 minutes at 95 to 100 ℃, the toluenesulphonic acids 2-fluorine ethyl ester that then in 2 hours, adds 2.98 kilograms, and mixture heated 1.5 hours between 95-100 ℃, in 2 hours, add 2.73 kilograms toluenesulphonic acids 2-fluorine ethyl ester then again.After heating 4 hours, in 1.5 hours, add 0.82 kilogram tosylate, and under uniform temp, reaction mixture was heated 6 hours.
After the reaction mixture cooling, pour in 64 liters of frozen water, after filtration, the reaction product after the washing puts into 32 liters of methyl alcohol (one-tenth suspended substance) and stirred 30 minutes, filter and drying after (5.02 kilograms in the crystal that obtains, 80.0%) is the purpose product, fusing point 188-190 ℃.
Analyze C
14H
11F
4NO
3, calculated value (%), C, 53.00;
H,3.50;N,4.42
Analytical value (%), C, 52.99;
H,3.40;N,4.47
Example 2
6.8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-4-oxygen-7-(1-piperazine)-the 3-quinoline carboxylic acid ethyl ester
The 210 gram 6.7.8-three fluoro-1-(2-fluoro ethyls that example 1 is obtained)-1,4-dihydro-4-oxygen-3-quinoline carboxylic acid ethyl ester is added in 50 ℃ of hot solution of 380 gram piperazines (being dissolved in 840 milliliters of methyl-sulphoxides), then temperature of reaction is elevated to 59 ℃, after 30 minutes, add 70 gram carboxylicesterss, under agitation condition, the temperature that keeps reaction mixture is between 55 to 60 ℃, in reaction mixture, add chloroform then, till reaction mixture becomes homogeneous phase, be poured into subsequently in 3.5 liters of frozen water that contain 130 gram salt of wormwood, stir mixture, and tell organic layer, water layer is with chloroform extracting twice, the chloroform of collecting mutually laminated and after, use the saturated common salt water washing, anhydrous sodium sulfate drying, and under reduced pressure be concentrated into crystallization and separate out, last in the reaction mixture 2 liters of hot acetones of adding, the crystal that filtration obtains is expecting compound (242 gram), fusing point 193-195 ℃, filtering-depositing can obtain 32 gram products for the second time, and filtering-depositing can obtain 24 gram products for the third time.
Example 3
6.8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-7-(4-methyl isophthalic acid-piperazine)-4-oxygen-3-quinoline carboxylic acid ethyl ester
A, 5.02 kilograms of (15.8 mol) esters that example 1 is obtained join in 15.1 liters of methyl-sulphoxide hot solution (65 ℃) of 3.16 kilograms of (31.6 mol) N methyl piperazines.
The temperature of mixture rose to 85 ℃ automatically in 30 minutes, by heating, in 1.5 hours, keep temperature of reaction between 85 to 90 ℃, the cooling back adds 35 premium on currency diluted mixture things just can obtain product, the product that filtration obtains obtain after with the vinyl acetic monomer recrystallization 5.71 kilograms (90.8%) 6,8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-7-(4-methyl isophthalic acid-piperazine)-4-oxygen-3-quinoline carboxylic acid ethyl ester, fusing point 163-165 ℃.
B, 9.5 gram (0.03 mol) esters that example 1 is obtained have joined 6 gram (0.06 mol) N-methyl
In 28.5 milliliters of acetonitrile hot solution of piperazine in (65 ℃), with reaction mixture reflux 5 hours, after the cooling, promptly get crystalline product then with 67 ml water diluted mixture things, with just obtaining purpose product 10.7 grams (89.9%), fusing point 160-163 ℃ behind the vinyl acetic monomer recrystallization.
C, the 9.5 gram esters that example 1 is obtained join in 28.5 milliliters of toluene hot solution (65 ℃) of 6 gram N methyl piperazines, then with reaction mixture reflux 4 hours, behind the concentrating under reduced pressure, promptly get crystalline product with 67 ml water diluted reaction mixtures, with just obtaining purpose product 7.8 grams (65.5%), 159 to 162 ℃ of fusing points behind the vinyl acetic monomer recrystallization.
D, the 9.5 gram esters that example 1 is obtained join in the 38.5 milliliters of spies-butanols hot solution (65 ℃) of 6 gram N methyl piperazines, then with reaction mixture reflux 7 hours, after the cooling, with 67 ml water diluted mixture things, obtain crystalline product, with just obtaining purpose product 10.2 grams (85.7%), 161 to 163 ℃ of fusing points behind the vinyl acetic monomer recrystallization.
E, the 9.5 gram esters that example 1 is obtained join in 28.5 milliliters of dimethyl formamide hot solution (65 ℃) of 6 gram N methyl piperazines, in 30 minutes, the temperature of mixture is raised to 85 ℃ automatically, by heating, in 7 hours, maintain the temperature between 85 to 90 ℃, after the cooling, just can obtain crystalline product with 67 ml water diluted mixture things, behind the vinyl acetic monomer recrystallization, obtain the purpose product (81.5%) of 9.7 grams, fusing point 162-164 ℃.
Analyze C
19H
22F
3N
3O
3, calculated value (%), C, 57.42;
H,5.58;N,10.57
Analytical value (%), C, 57.48;
H,5.49;N,10.56
Example 4
6.8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-7-(4-methyl isophthalic acid-piperazine)-4-oxygen-3-quinoline carboxylic acid
A, 5.71 kilograms of esters that example 3 is obtained have joined 1.81 kilograms of sodium hydroxide, in 80 ℃ of hot solution of 61 premium on currency, then reaction mixture is heated to 90 ℃ and kept 20 to 30 minutes, kept again 5 minutes at 90 ℃ then, be adjusted to 6 by adding 4 kilograms of pH values of acetic acid of 68% with reaction mixture, cooling, filtration obtains the crystalline precipitate thing, it is dissolved in the mixture of 68% acetic acid (4.1 liters) and water (33 liters), with 0.4 kilogram of activated carbon treatment, when after the filtration filtrate being heated to 40 ℃, add concentration and be 17.3 kilograms in 35% sulfuric acid, cooling, after the filtration with the sulfate precipitation of collecting, recrystallization in 91 liters water, and then vitriol is dissolved in the solution of 1.57 kilograms of sodium hydroxide and 61 premium on currency, then with 0.4 kilogram of activated carbon treatment solution, filtrate is adjusted to 7.5 ± 0.2 with pH value for about 2.5 liters with 68% acetum, the throw out that filtration obtains joins in 55 liters of ethanol or the methyl alcohol, and stirred 30 minutes, filter, be drying to obtain 269.5 ℃ of 4.48 kilograms of (84.4%) fusing points of purpose product.
Analyze C
17H
18F
3N
3O
3, calculated value (%), C, 55.28;
H,4.91;N,11.38
Analytical value (%), C, 55.42;
H,4.79;N,11.38
B, with 6.8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-4-oxygen-7-(1-
Piperazine)-3-quinoline carboxylic acid ethyl ester 297 grams, the mixture of 600 milliliters in formic acid and 39% formalin, refluxed 2 hours, concentrating under reduced pressure then, add 500 ml waters in the resistates of mixture, enriched mixture adds 3 liters of hot water, and is heated to 80 ℃ in resistates once more, under agitation subsequently, handle with containing the 160 gram sodium hydroxide alkalescence aqueous solution, continue stirring and become homogeneous phase until reaction mixture, then restir is 10 minutes, add 3 liters of hot water then, and be heated to 70-80 ℃, with in 80 milliliters of acetic acid and after, collect the washing with alcohol of filtering-depositing with three times of water and 2 times, recrystallization can obtain 6 in methyl-sulphoxide at last, 8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-7-(4-methyl isophthalic acid-piperazine)-4-oxygen-3-quinoline carboxylic acid 272 grams, 269 ℃ of fusing points
Analyze C
17H
18F
3N
3O
3, calculated value (%) C, 55.28;
H,4.91;N,11.38
Analytical value (%) C, 55.47;
H,4.82;N,11.36
Example 5
6.8-two fluoro-1-(2-fluoro ethyls)-1,4-dihydro-4-oxygen-7-(1-piperazine) quinoline-3-carboxylic acid
The described method of use-case 4a, the ester that saponification example 2 obtains.
By adding acetic acid the pH value of reaction mixture is adjusted at 7 to 8 o'clock, promptly obtains the purpose compound of a crystal water, 263 ℃ of fusing points (decomposition).
Analyze C
16H
16F
3N
3O
3.H
2O, calculated value (%), C, 51.48;
H,4.86;N,11.26
Analytical value (%), C, 51.26;
H,4.78;N,11.26
Test 1 anti-microbial activity
The anti-microbial activity of The compounds of this invention is by Gram-positive (G
+) and Gram-negative (G
-) two bacterioids, (Chemo-Therapy therapy, 22,1126 pages, 1974) of examining and determine with the dilution method of scoring of the nutrient agar of standard.
The anti-microbial activity test-results such as the table 1 of The compounds of this invention and known antiseptic-germicide nalidixic acid (NA).The compounds of this invention has higher anti-microbial activity than NA acid to gram-bacteria.
Table 1 anti-microbial activity
(minimum limit concentration, mcg/ml)
Claims (2)
1, the technology of preparation molecule formula IV compound
Here R
1Be: hydrogen atom or methyl.
This is a molecule formula III compound saponified product.
Here R is: the low molecular weight alkyl of 1 to 3 carbon atom
R
1Be: hydrogen atom or methyl
This compound is to be made by the reaction of the compound of the compound of molecule formula II and molecule formula I.
The R here
1With the molecule formula III, the R of (IV)
1Identical.
Here X is: halogen atom, R is identical with the R of molecule formula III.
2, the preparation molecular formula (technology of compound of IV-a)
This is molecular formula (the compound saponified product of III-b)
Here R is: the low molecular weight alkyl of 1 to 3 carbon atom
This compound is that (compound and the formaldehyde of III-a), the formic acid reaction makes by molecular formula.
(R of III-b) is identical for the R here and molecular formula.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN85101662A CN1010311B (en) | 1985-03-20 | 1985-04-01 | Process for preparing quinoline carboxylic acid derivatives |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA852065A ZA852065B (en) | 1985-03-20 | 1985-03-20 | A process for the preparation of quinoline carboxylic acid derivatives |
CN85101662A CN1010311B (en) | 1985-03-20 | 1985-04-01 | Process for preparing quinoline carboxylic acid derivatives |
Publications (2)
Publication Number | Publication Date |
---|---|
CN85101662A true CN85101662A (en) | 1987-01-17 |
CN1010311B CN1010311B (en) | 1990-11-07 |
Family
ID=25741461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN85101662A Expired CN1010311B (en) | 1985-03-20 | 1985-04-01 | Process for preparing quinoline carboxylic acid derivatives |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1010311B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105198904A (en) * | 2014-06-25 | 2015-12-30 | 上虞京新药业有限公司 | Preparing method for levofloxacin and ofloxacin |
-
1985
- 1985-04-01 CN CN85101662A patent/CN1010311B/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105198904A (en) * | 2014-06-25 | 2015-12-30 | 上虞京新药业有限公司 | Preparing method for levofloxacin and ofloxacin |
CN105198904B (en) * | 2014-06-25 | 2017-08-15 | 上虞京新药业有限公司 | The preparation method of lavo-ofloxacin and Ofloxacin |
Also Published As
Publication number | Publication date |
---|---|
CN1010311B (en) | 1990-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4553490B2 (en) | New manufacturing method | |
CN1687074A (en) | Post processing method for preparing levo-ofloxacin | |
CN1025028C (en) | Process for preparing quinoline carboxylic acid derivatives | |
JPH0148911B2 (en) | ||
CN85101662A (en) | The technology of preparation quinoline carboxylic acid derivative | |
JPH0374230B2 (en) | ||
CN102827015A (en) | Preparation method of 5-aminolevulinic acid (ALA) hydrochloride | |
CN1039423A (en) | 2, the preparation method of 2-dehydration-1-(β-D-arabinofuranosyl adenin base) thymus pyrimidine | |
CN101781264A (en) | Production method of 1-methyl-5-mercapto-1,2,3,4-tetrazole | |
JPH0450313B2 (en) | ||
CN1011410B (en) | Quinolonecar boxylic acid derivatives and their preparation | |
JPH0416474B2 (en) | ||
JP3684546B2 (en) | Production of α, α-dimethylphenylacetic acid from α, α-dimethylbenzyl cyanide under normal pressure | |
CN111320622A (en) | Method for synthesizing moxifloxacin hydrochloride | |
CN1012501B (en) | Quinolonecarboxylic acid derivatives and their preparation | |
SU1584751A3 (en) | Method of producing anhydrides of 6-fluoro-7-chloro-1-methylamino-4-oxo-1,4-dihydroquinoline-3-carbolic acid and boric acids | |
WO1987003595A1 (en) | Norfloxacin intermediate | |
CN1010313B (en) | Process for preparing quinolocarboxylic acid derivatives | |
CN114539244B (en) | Preparation method of moxifloxacin hydrochloride | |
CN112759590B (en) | Preparation method of moxifloxacin | |
CN112552299B (en) | Preparation method of linagliptin for treating type II diabetes | |
CN1047774C (en) | Prepn of azadiphenyl cycloheptyl ketenes | |
CN87100838A (en) | The novel method of preparation 4-ethanoyl isoquinolines compound | |
CN1043712A (en) | The preparation method of quinoline carboxylic acid derivative | |
Heuser et al. | Streptomycin Purification and Crystallization1 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C13 | Decision | ||
C14 | Grant of patent or utility model | ||
C17 | Cessation of patent right |